| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACCO | Common Stock | Options Exercise | $697,213 | +92,838 | +33% | $7.51 | 371,165 | 02 Mar 2022 | Direct | |
| transaction | ACCO | Common Stock | Sale | $793,848 | -92,838 | -25% | $8.55 | 278,327 | 02 Mar 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACCO | Stock Option (right to buy) | Options Exercise | $0 | -92,838 | -100% | $0.000000* | 0 | 02 Mar 2022 | Common Stock | 92,838 | $7.51 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | This price reflects the weighted average sale price for the shares, which were sold in multiple transactions at prices that ranged from $8.55 to $8.57. Upon request of the SEC staff, the issuer, or a security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. |
| F2 | Nonqualified employee stock options granted under the Issuer's Amended and Restated 2011 Incentive Plan. One-third of original grant vests annually. Options expire seven years from the grant date, if not earlier terminated or exercised in full, subject to acceleration as provided in said Plan. |